Life Technologies to Market Gen-Probe's Aneuploidy Kits | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies will commercialize Gen-Probe's Elucigene QST*R aneuploidy test kits under the Applied Biosystems name in certain markets around the world, the firm announced over the weekend.

Life Technologies will sell the test kits in Eastern Europe, Asia, Africa, Australia, Latin America, and Canada, under the agreement. However, the kits will not be available for sale in the US.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.